Results 101 to 110 of about 411,617 (199)

Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study. [PDF]

Int J Endocrinol
Oe Y, Nomoto H, Nakamura A, Kuwabara S, Takahashi Y, Yasui A, Izumihara R, Miya A, Kameda H, Cho KY, Atsumi T.   +10 more
europepmc   +1 more source

Patient safety and minimizing risk with insulin administration – role of insulin degludec

, 2014
Myint M Aye,1 Stephen L Atkin21Hull Royal Infirmary, Michael White Diabetes Centre, Hull, UK; 2Weill Cornell Medical College Qatar, Qatar Foundation, Doha, QatarAbstract: Diabetes is a lifelong condition requiring ongoing medical care and patient self ...
Aye MM, Atkin SL
core  

Efficacy and safety of insulin degludec/insulin aspart biosimilar B01711 vs originator insulin degludec/insulin aspart in Chinese patients with type 2 diabetes inadequately controlled on basal or premixed insulin: A multicenter, randomized, open-label, phase 3 study. [PDF]

J Diabetes Investig
Gao L, Cheng Z, Ma G, Cai X, Wang X, Lu Y, Li Z, Li W, Zhao S, Li X, Song C, Gao Y, Geng J, Cao H, Sun J, Ji L.   +15 more
europepmc   +1 more source

Long-lasting hypoglycemia through insulin degludec during acute kidney injury after diabetic ketoacidosis: A case report. [PDF]

Clin Pediatr Endocrinol
Kawashima S, Suzuki T, Shima H, Suzuki D, Kamimura M, Kikuchi A, Kanno J.   +6 more
europepmc   +1 more source

Glycemic Efficacy and Safety by Using Insulin Degludec and Aspart Guided by a Clinical Decision Support System in Non-Critically Ill Inpatients with Type 2 Diabetes Mellitus. [PDF]

Biosensors (Basel)
Aberer F, Hochfellner DA, Baumann PM, Höll B, Beck P, Pieber TR, Mader JK.   +6 more
europepmc   +1 more source

Once-weekly insulin icodec versus once-daily insulin degludec for type 2 diabetes in China: A cost-utility and budget impact analysis. [PDF]

Diabetes Obes Metab
Tong X, Zhang Y, Zhang L, Zhang L.
europepmc   +1 more source

Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia. [PDF]

Malays Fam Physician, 2023
Chan SP, Mumtaz M, Ratnasingam J, Tan ATB, Lim SC, Rosman A, Chee KH, Lim SK, Yew SS, Mohd Yusof BN, Lau BK, Kassim SB, Mohamed M.   +12 more
europepmc   +1 more source

In-Hospital Management of Hyperglycemia: The Role of Insulin Degludec. [PDF]

Diabetes Ther
Wangnoo SK, Baruah MP, Lodha S, Sanyal D, Goyal R, Sooragonda BG, Chandrasekaran S, Vijay Kumar G.   +7 more
europepmc   +1 more source

Preserved pharmacokinetics and pharmacodynamics of insulin degludec and liraglutide when administered as insulin degludec/liraglutide in a Chinese population. [PDF]

J Diabetes Investig, 2022
Liu H, Luo B, Chen X, Ingwersen SH, Jia T, Vestergård Jacobsen L, Hu P.   +6 more
europepmc   +1 more source

Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial. [PDF]

Diabetes Obes Metab
Thammakosol K, Jantarapootirat M, Traiwanatham S, Sriphrapradang C.   +3 more
europepmc   +1 more source